Clinical Trial: Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704684) titled 'Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine' on July 09.

Brief Summary: The main objective of the study will be to assess the efficacy and safety of Sacubitril/Allisartan (240mg) and Amlodipine (5mg) in patients with essential hypertension uncontrolled after 4-week treatment with Amlodipine (5mg).

Study Start Date: June 28, 2023

Study Type: INTERVENTIONAL

Condition: Essential Hypertension

Intervention: DRUG: Experimental: Sacubitril/Allisartan and Amlodipine Group

Drug: Sacubitril/Allisartan and Amlodipine

DRUG: Active Comparator: Amlodipine Group

Drug: Am...